A detailed history of Bell Investment Advisors, Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 18 shares of SAGE stock, worth $97. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 18 -0.0%
Holding current value
$97
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$16.75 - $48.98 $234 - $685
-14 Reduced 43.75%
18 $0
Q2 2022

Aug 12, 2022

SELL
$27.52 - $37.99 $82 - $113
-3 Reduced 8.57%
32 $1,000
Q4 2021

Feb 14, 2022

BUY
$37.06 - $47.11 $963 - $1,224
26 Added 288.89%
35 $1,000
Q3 2021

Nov 12, 2021

BUY
$40.26 - $57.37 $362 - $516
9 New
9 $0

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.